Top pharma firm clinches coronavirus vaccine deal

0
1

NEW YORK: US drugmaker Pfizer said on Thursday that early data has helped it identify a drug candidate with the potential to help treat patients infected with the novel coronavirus. It also finalized a plan to develop a coronavirus vaccine in partnership with German drugmaker BioNTech and said the companies hope to produce millions of vaccines by the end of 2020.

NO COMMENTS